Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2026-05-25 @ 10:02 AM
Study NCT ID:
NCT05950334
Status:
COMPLETED
Last Update Posted:
2025-08-22
First Post:
2023-07-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
FT522 With Rituximab in Relapsed/Refractory B-Cell Lymphoma (FT522-101)
Sponsor:
Organization: